Autologous bone marrow mononucleated cell preparation for the clinical treatment of acute myocardial infarction and peripheral arterial disease

References

• Kuci S, Kuci Z, Latifi-Pupovci H, Niethammer D, Handgretinger R, Schumm M, . Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine. Curr Stem Cell Res Ther. 2009;4:107–17.
   PubMed Web of Science ®Google Scholar
• Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest. 1968; 97(Suppl):77–89.
   Google Scholar
• Fibbe WE, Noort WA. Mesenchymal stem cells and hematopoietic stem cell transplantation. Ann NY Acad Sci. 2003; 996:235–44.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, . Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.
   PubMed Web of Science ®Google Scholar
• Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA. 2000;97:3213–8.
   PubMed Web of Science ®Google Scholar
• Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res. 2004;95:343–53.
   PubMed Web of Science ®Google Scholar
• Kinnaird T, Stabile E, Burnett MS, Epstein SE. Bone- marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ Res. 2004;95:354–63.
   PubMed Web of Science ®Google Scholar
• Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008;103: 1204–19.
   PubMed Web of Science ®Google Scholar
• Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, . Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 2005;11:367–8.
   PubMed Web of Science ®Google Scholar
• Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, . Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006;20:661–9.
   PubMed Web of Science ®Google Scholar
• Rota M, Kajstura J, Hosoda T, Bearzi C, Vitale S, Esposito G, . Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci USA. 2007;104:17783–8.
   PubMed Web of Science ®Google Scholar
• Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, . Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007;167:989–97.
   PubMed Web of Science ®Google Scholar
• Stamm C, Kleine HD, Choi YH, Dunkelmann S, Lauffs JA, Lorenzen B, . Intramyocardial delivery of CD133 + bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg. 2007;133:717–25.
   PubMed Web of Science ®Google Scholar
• Sürder DSJ, Moccetti T, Astori G, Rufibach K, Plein S, Lo Cicero V, . Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI). Am Heart J. 2010;160:58–64.
   PubMed Web of Science ®Google Scholar
• Standards of Practice Committee of the Society of Cardiovascular and Interventional Radiology. Guidelines for percutaneous transluminal angioplasty. Radiology. 1990;177:619–26.
   PubMed Web of Science ®Google Scholar
• Valentine RJ, Myers SI, Inman MH, Roberts JR, Clagett GP. Late outcome of amputees with premature atherosclerosis. Surgery. 1996;119:487–93.
   Google Scholar
• Schainfeld RM, Isner JM. Critical limb ischemia: nothing to give at the office? Ann Intern Med. 1999;130:442–4.
   Google Scholar
• Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344:1608–21.
   PubMed Web of Science ®Google Scholar
• Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis. 2010;209:10–7.
   PubMed Web of Science ®Google Scholar
• U. S. Department of Health and Human Services, Food and Drug Administration: Center for Biologics Evaluation and Research, Rockville, MD. April 2008.
   Google Scholar
• European Pharmacopoeia, 7th, 2010. EDQM, Strasbourg, France and US Pharmacopoeia, 2011 Rockville, Maryland, USA.
   Google Scholar
• Soncin S, Lo Cicero V, Astori G, Soldati G, Gola M, Surder D, . A practical approach for the validation of sterility, endotoxin and potency testing of bone marrow mononucleated cells used in cardiac regeneration in compliance with good manufacturing practice. J Transl Med. 2009;7:78.
   Google Scholar
• Dawn B, Bolli R. Bone marrow for cardiac repair: the importance of characterizing the phenotype and function of injected cells. Eur Heart J. 2007;28:651–2.
   Google Scholar
• Seeger FH, Tonn T, Krzossok N, Zeiher AM, Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J. 2007;28:766–72.
   PubMed Web of Science ®Google Scholar
• Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, . Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004;109:1615–22.
   PubMed Web of Science ®Google Scholar
• Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, . Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation. 2003;108:2212–8.
   PubMed Web of Science ®Google Scholar